We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Why Pharma Is Rethinking Its Data Integration Strategy

Article   Aug 21, 2018 | by Nimita Limaye, Nymro Clinical Consulting Services and Rohan Limaye, UMass Amherst

 
Why Pharma Is Rethinking Its Data Integration Strategy – the Criticality of Data Integration
 
 
Advertisement
 

RELATED ARTICLES

Stay Up-to-Date With COVID-19 Vaccine Development

Article

Technology Networks is committed to keeping you updated with the latest research in this space. In this article, you'll find a curation of our latest COVID-19 vaccine-related content.

READ MORE

A Leading Voice for T-Cell Expertise During COVID-19 and Beyond

Article

The unprecedented scale of global scientific collaboration, including the establishment of expert consortia, has played an important part in addressing the COVID-19 pandemic. We spoke to Professor Danny Altmann, chair of the Global T cell Expert Consortium (GTEC) about the role that T cells have in viral infections like SARS-CoV-2 and what GTEC is hoping to achieve.

READ MORE

Cell Culture Contamination: Mycoplasma and Problematic Cell Lines Continue To Cause Concern

Article

Cell culture contamination is a major concern for biological and biomedical research, as well as for biologics therapeutics production. Here, we take a closer look at mycoplasma contamination and problematic cell lines.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE